ADVANCES IN CHRONIC KIDNEY DISEASE

Scope & Guideline

Exploring the Frontiers of Nephrology Research

Introduction

Welcome to your portal for understanding ADVANCES IN CHRONIC KIDNEY DISEASE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1548-5595
PublisherW B SAUNDERS CO-ELSEVIER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2004 to 2022 (coverage discontinued in Scopus)
AbbreviationADV CHRONIC KIDNEY D / Adv. Chronic Kidney Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899

Aims and Scopes

The journal 'Advances in Chronic Kidney Disease' focuses on disseminating innovative research and clinical insights pertaining to chronic kidney disease (CKD) and its associated management. It emphasizes educational advancements, emerging technologies, and the interplay between kidney health and systemic diseases.
  1. Nephrology Education and Training:
    This area encompasses the development and enhancement of nephrology training programs, including curricula for nephrology fellows, physician assistants, and nurse practitioners, focusing on modern educational techniques and integrated learning approaches.
  2. Artificial Intelligence and Machine Learning Applications:
    The journal explores the integration of AI and machine learning in nephrology, particularly in diagnostics, risk assessment, and treatment optimization for various kidney conditions, highlighting advances in technology for improving patient outcomes.
  3. Metabolic Acidosis and Its Clinical Implications:
    Research covers the understanding of metabolic acidosis in CKD patients, including its pathophysiology, effects on health, and management strategies, emphasizing its significance in chronic disease care.
  4. Pediatric to Adult Transition in Kidney Care:
    This focus area addresses the unique challenges and considerations when transitioning young patients with CKD from pediatric to adult care, highlighting the importance of continuity in healthcare services.
  5. Onconephrology and Cancer-Kidney Interactions:
    Research delves into the intersection of kidney disease and cancer, including the impact of cancer treatments on kidney health and management strategies for affected patients.
  6. Health Policy and Kidney Disease Management:
    The journal examines health policy developments affecting kidney disease care, including reimbursement models, access to care, and initiatives aimed at improving kidney health outcomes.
Recent publications in 'Advances in Chronic Kidney Disease' reflect evolving trends and emerging themes that are gaining traction in the field. These areas indicate where research and clinical practice are likely heading in the near future.
  1. Integration of Artificial Intelligence and Data Analytics:
    There is a growing emphasis on the role of AI and data analytics in nephrology, particularly regarding predictive modeling, patient management, and enhancing clinical decision-making processes.
  2. Focus on Metabolic Acidosis and Its Management:
    Recent discussions highlight the critical need to address metabolic acidosis in CKD patients, showcasing research that explores its health impacts and innovative management strategies.
  3. Enhancements in Nephrology Education and Curriculum Development:
    A notable trend is the focus on improving nephrology education, including curriculum reforms that integrate modern learning techniques and address healthcare disparities.
  4. Onconephrology as an Emerging Specialty:
    The intersection of oncology and nephrology is becoming increasingly relevant, with more research dedicated to understanding how cancer treatments affect kidney health and vice versa.
  5. Policies and Innovations in Kidney Disease Care:
    Research is increasingly addressing the implications of health policies on kidney disease management, emphasizing innovative care models and strategies to improve patient outcomes.

Declining or Waning

While the journal continues to highlight various aspects of nephrology, certain themes appear to be declining in prominence based on recent publications. These waning scopes suggest shifts in research focus and clinical priorities within the field.
  1. Traditional Dialysis Techniques:
    Papers focusing on conventional dialysis methods have decreased as the field moves towards exploring more innovative and patient-centered approaches, such as home hemodialysis and continuous renal replacement therapy.
  2. Basic Renal Physiology Research:
    Although fundamental research remains essential, there has been a noticeable shift towards applied research and clinical applications, resulting in fewer publications centered solely on basic renal physiology.
  3. General Kidney Disease Management without Specialization:
    The trend appears to be moving away from broad discussions of kidney disease management towards specialized areas such as onconephrology or AI applications, reflecting a more focused approach to research.
  4. Historical Perspectives on Nephrology:
    Research that emphasizes historical perspectives or past practices within nephrology seems to be waning, as the field increasingly focuses on contemporary issues and future directions.

Similar Journals

Journal of Renal Injury Prevention

Advancing renal health through innovative research.
Publisher: NIKAN RESEARCH INSTISSN: 2345-2781Frequency: 4 issues/year

Journal of Renal Injury Prevention, published by NIKAN RESEARCH INST, is an essential resource in the fields of nephrology and urology, catering to the growing need for specialized knowledge in the prevention and management of renal injuries. Since its establishment in 2017, this journal has worked diligently to contribute to the global discourse on renal health, exploring innovative strategies and emerging therapies. With an ISSN of 2345-2781 and an E-ISSN of 2345-2781, it aims to provide high-quality research that addresses critical aspects of kidney injuries and their prevention. While currently classified in the Q4 quartile for both nephrology and urology, the journal aspires to enhance its impact by nurturing robust discussions among researchers and clinicians alike. The journal is based in Isfahan, Iran, and welcomes submissions that advance our understanding of renal pathology. Given its commitment to the advancement of medical science, the Journal of Renal Injury Prevention is poised to play a key role in shaping future research and clinical practices in the field.

CLINICAL NEPHROLOGY

Unlocking the future of nephrology, one article at a time.
Publisher: DUSTRI-VERLAG DR KARL FEISTLEISSN: 0301-0430Frequency: 12 issues/year

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.

Clinical and Experimental Nephrology

Bridging clinical practice and experimental research.
Publisher: SPRINGERISSN: 1342-1751Frequency: 6 issues/year

Clinical and Experimental Nephrology, published by SPRINGER, serves as a crucial platform for researchers and practitioners in the field of nephrology. With its roots dating back to 1999, the journal has made significant strides in exploring various dimensions of kidney health, thereby enriching our understanding of nephrological diseases. Aimed at fostering interdisciplinary dialogue, it covers a broad spectrum of topics from clinical practices to experimental research, evidenced by its ranked quartiles of Q2 in Nephrology and Q3 in both Physiology and Medical Physiology within its latest evaluation. Although not open access, the journal's rigorous peer-review process ensures the publication of high-quality research, making it a valuable resource for professionals, academic institutions, and students. The journal is located in Japan, with its editorial office situated at One New York Plaza, Suite 4600, New York, NY 10004, United States, reflecting its global influence and intent to disseminate critical findings in nephrology and beyond.

Kidney360

Transforming kidney care with impactful research.
Publisher: AMER SOC NEPHROLOGYISSN: 2641-7650Frequency: 12 issues/year

Kidney360 (ISSN: 2641-7650) is a prominent open-access journal published by the American Society of Nephrology, dedicated to advancing the field of nephrology and its intersecting medical disciplines. Established with a vision to foster innovative research and promote a deeper understanding of kidney health, this journal is positioned as a vital resource for nephrologists, researchers, and healthcare professionals. With its classification in Q1 in Nephrology and Q2 in Medicine (miscellaneous) for 2023, Kidney360 ranks favorably, highlighting its commitment to publish high-quality, impactful research, recognized in the top percentile of its field. The journal's accessible platform aims to disseminate knowledge effectively, making it an essential repository for cutting-edge studies, reviews, and clinical research. By encouraging collaboration across various disciplines, Kidney360 plays a critical role in shaping the future of nephrology and enhancing patient care on a global scale.

Nephrologie

Transforming kidney health through collaborative research.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7463Frequency: 6 issues/year

Nephrologie, published by Springer Heidelberg, is a vital addition to the field of nephrology, providing a dedicated platform for the dissemination of cutting-edge research and clinical practices in kidney health. With its ISSN 2731-7463 and E-ISSN 2731-7471, this journal facilitates open access to a range of articles aimed at enhancing understanding and treatment of renal disorders. Located in Germany, Nephrologie is recognized for its commitment to advancing nephrological knowledge despite being currently categorized in the Q4 quartile and holding a Scopus rank of #80/81 within its field, indicating its emerging potential in the academic landscape. Operating from Tiergartenstraße 17, D-69121 Heidelberg, Germany, the journal encompasses a diverse scope that includes original research, review articles, and clinical studies, fostering a collaborative environment among researchers, healthcare professionals, and students. As it converges between 2022 and 2024, Nephrologie positions itself as a crucial resource for those committed to improving renal patient care and outcomes.

Saudi Journal of Kidney Diseases and Transplantation

Connecting scholars to revolutionize kidney care.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-2442Frequency: 6 issues/year

Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.

Kidney International Supplements

Advancing kidney health through groundbreaking research.
Publisher: ELSEVIER SCIENCE INCISSN: 2157-1724Frequency:

Kidney International Supplements is a prestigious academic journal published by Elsevier Science Inc, specializing in the field of nephrology. With an impressive impact factor and ranked in the top percentile, it holds the esteemed position of Q1 in nephrology categories, reflecting its influential contribution to the academic community. Throughout its publication history from 2011 to 2022 and in the anticipated 2024 edition, the journal has provided a vital platform for disseminating high-quality research and insights, catering to professionals, researchers, and students dedicated to advancing kidney health. While it offers traditional access options, the journal is committed to promoting the highest standards of research integrity and innovation in nephrology. The journal plays an essential role in shaping the future of kidney disease treatment, levelling knowledge exchange across specialties, and fostering collaboration among experts in the field.

KIDNEY & BLOOD PRESSURE RESEARCH

Advancing Kidney Health and Blood Pressure Insights.
Publisher: KARGERISSN: 1420-4096Frequency: 12 issues/year

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

NEPHROLOGY

Advancing renal research for a healthier tomorrow.
Publisher: WILEYISSN: 1320-5358Frequency: 12 issues/year

NEPHROLOGY is a leading academic journal published by Wiley, dedicated to advancing research and discussions in the fields of Nephrology and Medicine. With an ISSN of 1320-5358, this journal has consistently demonstrated its significance and impact, reflecting a Q2 category ranking in both Medicine (miscellaneous) and Nephrology as of 2023. Covering a comprehensive range of topics since its inception in 1995, NEPHROLOGY provides a vital platform for researchers, practitioners, and students alike to explore the latest advancements, innovative treatments, and diverse challenges within the field. Although it does not operate under an open access model, the journal remains highly regarded, with a commendable Scopus rank of #27 out of 81 in Nephrology, positioning it in the 67th percentile among its peers. Located in the United Kingdom, NEPHROLOGY invites submissions that push the boundaries of knowledge, ultimately striving to enhance the understanding of renal health and disease.

Canadian Journal of Kidney Health and Disease

Elevating kidney health research to new heights.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.